A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.

Lignende værker

• Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
  af: Lissoni, P., et al.
  Udgivet: (1993)
• Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
  af: Lissoni, P., et al.
  Udgivet: (1992)
• Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
  af: Lissoni, P., et al.
  Udgivet: (1989)
• A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
  af: Lissoni, P., et al.
  Udgivet: (1996)
• Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
  af: Lissoni, P., et al.
  Udgivet: (1991)